Pages that link to "Q66961769"

The following pages link to Neurochemical and pharmacological studies on a new 5HT-uptake inhibitor, FG4963, with potential antidepressant properties (Q66961769):

Displaying 36 items.

• Pharmacological and biochemical studies with three metabolites of nomifensine (Q28325319) (← links)
• Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia (Q28377272) (← links)
• Comparative studies of a new 5HT-uptake inhibitor and some tricyclic thymoleptics (Q29042502) (← links)
• Effects of a single oral dose of 3-cyano-imipramine on serotonin uptake and content of platelets in healthy volunteers (Q34259257) (← links)
• The effect of some new antidepressants on apomorphine-induced hypothermia in mice (Q39276314) (← links)
• The interaction of desipramine and the 5-HT uptake inhibitors femoxetine and paroxetine with the acute hypotensive effect of guanethidine in conscious spontaneously hypertensive rats (Q39283070) (← links)
• Potent depletion of 5HT from monkey whole bloob by a new 5HT uptake inhibitor, paroxetine (FG 7051) (Q39633595) (← links)
• Reduction of whole blood serotonin in depressed patients treated with a new, selective serotonin-uptake inhibitor, femoxetine (Q39685531) (← links)
• Inhibition of 5-HT uptake into neurons and platelets in mice treated chronically with chlorimipramine and femoxetine (Q39690872) (← links)
• On the role of 5-hydroxytryptamine in drug-induced antinociception (Q40066941) (← links)
• Potent and long-lasting potentiation of two 5-hydroxytryptophan-induced effects in mice by three selective 5-HT uptake inhibitors (Q40671156) (← links)
• 6 Non-Tricyclic Antidepressants (Q41209500) (← links)
• Influence of the new 5-HT-uptake inhibitor paroxetine on hypermotility in rats produced by p-chloroamphetamine (PCA) and 4,?-dimethyl-m-tyramine (H 77/77) (Q41414317) (← links)
• Paroxetine: Pharmacokinetics, Tolerance and Depletion of Blood 5-HT in Man (Q41529131) (← links)
• Cardiovascular (ECG and systolic time intervals) and anticholinergic effects of repeated doses of femoxetine--a comparison with amitriptyline and placebo in healthy men. (Q43222409) (← links)
• Brain histamine receptors as targets for antidepressant drugs (Q44587875) (← links)
• Nialamide-induced hypermotility in mice treated with inhibitors of monoamine uptake, 5-HT antagonists and lithium (Q44898091) (← links)
• Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor (Q48255149) (← links)
• Effects of tianeptine on 5-hydroxyindoles and on the morphine-induced increase in 5-HT metabolism at the medullary dorsal horn level as measured by in vivo voltammetry in freely moving rats (Q48346731) (← links)
• Effects of thymoleptics on behavior associated with changes in brain dopamine. II. Modification and potentiation of apomorphine-induced stimulation of mice (Q48363399) (← links)
• Serotonergic involvement in phencyclidine-induced behaviors (Q48630301) (← links)
• Brain serotonergic neurons: Their role in a form of dominance-subordination behavior in rats (Q48631464) (← links)
• Femoxetine blocks the morphine-induced increase in 5-HT metabolism, as measured by in vivo voltammetry in the nucleus raphe magnus of freely-moving rats (Q48649841) (← links)
• Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers (Q48880119) (← links)
• Serotonergic mechanism in seizures kindled from the rabbit amygdala. (Q53774676) (← links)
• Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs (Q60050321) (← links)
• Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity (Q66941209) (← links)
• Inhibition of both MAO-A and MAO-B required for the production of hypermotility in mice with the 5HT uptake inhibitors chlorimipramine and femoxetine (Q67013697) (← links)
• Behavioral effects of thymoleptics in vervet monkeys (Cercopithecus aethiops) (Q67513341) (← links)
• Determination of ( )-(3R), (4S)-3-[(4methoxyphenoxy)methyl]-1-methyl-4-phenylpiperidine hydrochloride (FG 4963) in biological fluids using competition for adsorption to glass (Q67550131) (← links)
• Femoxetine and cimetidine: interaction in healthy volunteers (Q69690416) (← links)
• Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine (Q70528706) (← links)
• Metabolism of Femoxetine (Q71093418) (← links)
• Mechanism by which uptake inhibitors antagonize p-chloroamphetamine-induced depletion of brain serotonin (Q71194305) (← links)
• Effect of chronic tricylic antidepressant treatment on the serotoninergic autoreceptor: a microiontophoretic study in the rat (Q71447450) (← links)
• Antidepressant effect of femoxetine and desipramine and relationship to the concentration of amine metabolites in cerebrospinal fluid (Q72677722) (← links)